There are 28 resources available
Second-line Treatment for Advanced NSCLC
Presenter: L. Hendriks, NL
Session: Session 3 – Challenges and novel therapies in clinical oncology
Resources:
Slides
Prognostic and Predictive Biomarkers for IO
Presenter: S. Peters, CH
Session: Session 3 – Challenges and novel therapies in clinical oncology
Antibody Drug Conjugates and Bi-specific Ab
Presenter: D. Planchard, FR
Session: Session 3 – Challenges and novel therapies in clinical oncology
Resources:
Slides
Participants Clinical Case Discussion - Challenges in the Treatment of Long Survivors
Presenter: M. R. Pires, PT
Session: Session 3 – Challenges and novel therapies in clinical oncology
Resources:
Slides
Sequence for Biomarker Testing in Advanced NSCLC (IHC, PCR, NGS and More)
Presenter: K. M. Kerr, UK
Session: Session 4 – Hitting the target in 2022
Resources:
Slides
New Treatment Options for EGFRmut NSCLC
Presenter: T. S.K. Mok, HK
Session: Session 4 – Hitting the target in 2022
Resources:
Slides
The Patient with an EGFR or HER2 Exon 20 Insertion
Presenter: M. Garassino, US
Session: Session 4 – Hitting the target in 2022
Resources:
Slides
Participants Clinical Case Discussion - EGFR-mutated Adenocarcinoma
Presenter: O. Wiklander, SE
Session: Session 4 – Hitting the target in 2022
Resources:
Slides
Participants Clinical Case Discussion - HER-2 Mutation and Amplification in NSCLC
Presenter: S. T. Riva, IT
Session: Session 4 – Hitting the target in 2022
Resources:
Slides
New Treatment Options for Non-EGFR/HER2 Mutations
Presenter: F. Barlesi, FR
Session: Session 5 – Hitting even more targets in 2022
Resources:
Slides